GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1061-1082.
van Ettekoven CN, Liechti FD, Brouwer MC, et al. Global case fatality of bacterial meningitis during an 80-year period: a systematic review and meta-analysis. JAMA Netw Open. 2024;7(8):e2424802.
Thigpen MC, Whitney CG, Messonnier NE, et al.; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011;364(21):2016-2025.
Prasad N, Kobayashi M, Collins JP, et al. The epidemiology of bacterial meningitis in the United States during 2008–2023: an analysis of active, laboratory, population-based, multistate surveillance data. Lancet Reg Health Am. 2025;47:101120.
- US Centers for Disease Control and Prevention. Meningitis. Accessed May 5, 2025. https://www.cdc.gov/meningitis/index.html
Gundamraj V, Hasbun R. Viral meningitis and encephalitis: an update. Curr Opin Infect Dis. 2023;36(3):177-185.
Venkatesan A, Tunkel AR, Bloch KC, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114-1128.
- World Health Organization. Defeating meningitis by 2030: a global road map. June 24, 2021. Accessed May 5, 2025. https://www.who.int/publications/i/item/9789240026407
van de Beek D, Brouwer MC, Koedel U, et al. Community-acquired bacterial meningitis. Lancet. 2021;398(10306):1171-1183.
- Oliver SE, Moro P, Blain AE. Chapter 8: Haemophilus influenzae. May 21, 2024. Accessed May 5, 2025. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-8-haemophilus-influenzae.html
Kadambari S, Abdullahi F, Celma C, et al. Epidemiological trends in viral meningitis in England: prospective national surveillance, 2013–2023. J Infect. 2024;89(3):106223.
Kohil A, Jemmieh S, Smatti MK, et al. Viral meningitis: an overview. Arch Virol. 2021;166(2):335-345.
- US Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 8: meningococcal disease. October 30, 2024. Accessed May 5, 2025. https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-8-meningococcal-disease.html
van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-1859.
Wang AY, Machicado JD, Khoury NT, et al. Community-acquired meningitis in older adults: clinical features, etiology, and prognostic factors. J Am Geriatr Soc. 2014;62(11):2064-2070.
Weisfelt M, van de Beek D, Spanjaard L, et al. Community-acquired bacterial meningitis in older people. J Am Geriatr Soc. 2006;54(10):1500-1507.
Mount HR, Boyle SD. Aseptic and bacterial meningitis: evaluation, treatment, and prevention. Am Fam Physician. 2017;96(5):314-322.
Shukla B, Aguilera EA, Salazar L, et al. Aseptic meningitis in adults and children: diagnostic and management challenges. J Clin Virol. 2017;94:110-114.
- National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. NICE Guideline, No. 240. March 19, 2024. Accessed December 7, 2025. https://www.ncbi.nlm.nih.gov/books/NBK604183/
van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(suppl 3):S37-S62.
Nakao JH, Jafri FN, Shah K, et al. Jolt accentuation of headache and other clinical signs: poor predictors of meningitis in adults. Am J Emerg Med. 2014;32(1):24-28.
Thomas KE, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis. 2002;35(1):46-52.
Attia J, Hatala R, Cook DJ, et al. The rational clinical examination. Does this adult patient have acute meningitis? JAMA. 1999;282(2):175-181.
Akaishi T, Kobayashi J, Abe M, et al. Sensitivity and specificity of meningeal signs in patients with meningitis. J Gen Fam Med. 2019;20(5):193-198.
Kettler A, Claudius I. Pediatric high-risk conditions. Emerg Med Clin North Am. 2025;43(1):41-56.
Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010;126(5):952-960.
Amarilyo G, Alper A, Ben-Tov A, et al. Diagnostic accuracy of clinical symptoms and signs in children with meningitis. Pediatr Emerg Care. 2011;27(3):196-199.
McGill F, Heyderman RS, Michael BD, et al. The UK Joint Specialist Societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016;72(4):405-438.
Mintegi S, García S, Martín MJ, et al.; Meningitis Group of the Spanish Society of Pediatric Emergencies. Clinical prediction rule for distinguishing bacterial from aseptic meningitis. Pediatrics. 2020;146(3):e20201126.
Oostenbrink R, Moons KGM, Derksen-Lubsen AG, et al. A diagnostic decision rule for management of children with meningeal signs. Eur J Epidemiol. 2004;19(2):109-116.
Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284.
- World Health Organization. WHO guidelines on meningitis diagnosis, treatment and care. April 10, 2025. Accessed August 3, 2025. https://www.who.int/publications/i/item/9789240108042
Yelehe-Okouma M, Czmil-Garon J, Pape E, et al. Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol. 2018;32(3):252-260.
Lee SCM, Lueck CJ. Cerebrospinal fluid pressure in adults. J Neuroophthalmol. 2014;34(3):278-283.
Shahan B, Choi EY, Nieves G. Cerebrospinal fluid analysis. Am Fam Physician. 2021;103(7):422-428.
- National Institute for Health and Care Excellence. Evidence review for investigating and diagnosing suspected bacterial meningitis with cerebrospinal fluid parameters: meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. March 2024. Accessed December 7, 2025. https://pubmed.ncbi.nlm.nih.gov/38843359/
Olie SE, Staal SL, Groeneveld NS, et al. Validation and clinical implementation of cerebrospinal fluid C-reactive protein for the diagnosis of bacterial meningitis: a prospective diagnostic accuracy study. Lancet Reg Health Eur. 2025;53:101309.
Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):281-290.
Rafiei N, Subedi S, Harris PN, et al. Clinical and cost implication of Biofire FilmArray meningitis/encephalitis panel testing: a systematic review. Diagn Microbiol Infect Dis. 2025;112(3):116823.
Wright WF, Pinto CN, Palisoc K, et al. Viral (aseptic) meningitis: a review. J Neurol Sci. 2019;398:176-183.
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34-e65.
Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327.
Onita T, Ikawa K, Ishihara N, et al. Cerebrospinal pharmacokinetic analysis and pharmacodynamic evaluation of ceftriaxone in pediatric patients with bacterial meningitis. J Clin Phar Therapeutics. 2024;1:4684986.
Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA. 2022;328(21):2147-2154.
Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015(9):CD004405.
Hansen AE, Vestergaard HT, Dessau RB, et al. Long-term survival, morbidity, social functioning and risk of disability in patients with a herpes simplex virus type 1 or type 2 central nervous system infection, Denmark, 2000–2016. Clin Epidemiol. 2020;12:745-755.
Kiyani M, Hodges SE, Adil SM, et al. Outcomes and health care resource utilization of adult bacterial meningitis in the United States. Neurol Clin Pract. 2021;11(2):117-126.
Zainel A, Mitchell H, Sadarangani M. Bacterial meningitis in children: neurological complications, associated risk factors, and prevention. Microorganisms. 2021;9(3):535.
- US Centers for Disease Control and Prevention. Pneumococcal vaccine recommendations. October 26, 2024. Accessed May 5, 2025. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html
- US Centers for Disease Control and Prevention. Meningococcal vaccine recommendations. July 1, 2025. Accessed January 2, 2026. https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html
- US Centers for Disease Control and Prevention. Child immunization schedule notes. December 8, 2025. Accessed January 2, 2026. https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-notes.html
- American Academy of Family Physicians. Immunization schedules. 2025. Accessed January 17, 2026. https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/immunization-schedules.html
- American Academy of Family Physicians. Meningococcal disease vaccine. Accessed January 17, 2026. https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/meningococcal-disease-vaccine.html
- US Centers for Disease Control and Prevention. About the vaccine: MMR and MMRV vaccine composition and dosage. January 26, 2021. Accessed July 28, 2025. https://www.cdc.gov/vaccines/vpd/mmr/hcp/about.html
Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1-41.
Kobayashi M, Leidner AJ, Gierke R, et al. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2024. MMWR Morb Mortal Wkly Rep. 2025;74(1):1-8.
- US Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 2: Haemophilus influenzae invasive disease. October 30, 2024. Accessed May 5, 2025. https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-2-haemophilus-influenzae.html
Briere EC, Rubin L, Moro PL, et al.; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-01):1-14.
Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, et al. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2013(10):CD004785.
- US Centers for Disease Control and Prevention. Clinical guidance for pneumococcal disease. February 6, 2024. Accessed May 5, 2025. https://www.cdc.gov/pneumococcal/hcp/clinical-guidance/
- ACOG Committee Opinion, number 797. Prevention of group B streptococcal early-onset disease in newborns. June 2019. Accessed May 5, 2025. https://www.acog.org/-/media/project/acog/acogorg/clinical/files/committee-opinion/articles/2020/02/prevention-of-group-b-streptococcal-early-onset-disease-in-newborns.pdf
Bamberger DM. Diagnosis, initial management, and prevention of meningitis. Am Fam Physician. 2010;82(12):1491-1498.